Brandon D L Marshall
Overview
Explore the profile of Brandon D L Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
342
Citations
6467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gray J, Krieger M, Skinner A, Parker S, Basta M, Reichley N, et al.
BMC Public Health
. 2025 Mar;
25(1):915.
PMID: 40055691
Objectives: The escalating overdose crisis in the United States points to the urgent need for new and novel data tools. Overdose data tools are growing in popularity but still face...
2.
Shaw L, Brown E, Creegan E, Bertrand T, Ogundare S, Park C, et al.
J Public Health Manag Pract
. 2025 Feb;
PMID: 39964190
Objective: Improved harm reduction approaches are needed to address the ongoing opioid epidemic in the United States. The study aimed to evaluate the statewide implementation of harm reduction vending machines...
3.
Weiss N, Forkus S, Raudales A, Kiefer R, Thomas E, Goldstein S, et al.
Int J Ment Health Addict
. 2025 Feb;
22(6):3510-3519.
PMID: 39897538
Objective: Efforts to prevent opioid overdose mortality have rapidly expanded, including community-based distribution of naloxone to laypeople. In turn, responding to the opioid overdose crisis has increasingly fallen on the...
4.
Behrends C, Trinidad A, Nolan M, Dolatshahi J, Kingsepp A, Jordan A, et al.
J Urban Health
. 2025 Jan;
PMID: 39820975
From 2014 to 2017, the drug overdose death rate per 100,000 in New York City (NYC) increased by 81%, with 57% of overdoses in 2017 involving the opioid fentanyl. In...
5.
Chan P, Goedel W, Li Y, Mena L, Patel R, Marshall B, et al.
J Acquir Immune Defic Syndr
. 2025 Jan;
98(5):465-472.
PMID: 39780304
Background: HIV continues to disproportionately affect men who have sex with men (MSM) in the United States. Pre-exposure prophylaxis (PrEP) is effective, but disparities persist. Limited studies have conducted systematic...
6.
Chambers L, Welwean R, Cho D, Langdon K, Li Y, Hallowell B, et al.
Subst Use Misuse
. 2024 Dec;
60(3):381-392.
PMID: 39618048
Background: Emergency department (ED) visits are an opportunity to provide prevention services to people at high risk of overdose. Considering patients' resources to initiate and sustain recovery ("recovery capital") may...
7.
Shaw L, Hallowell B, Paiva T, Schulz C, Daly M, Borden S, et al.
J Addict Med
. 2024 Nov;
PMID: 39591630
Background: Buprenorphine and methadone are US Food and Drug Administration-approved medications for opioid use disorder (MOUD). Although utilization of MOUD was increasing pre-COVID-19, it is not well understood how this...
8.
Shihipar A, Marshall B
Int J Drug Policy
. 2024 Nov;
135():104659.
PMID: 39571241
No abstract available.
9.
10.
Bhondoekhan F, Li Y, Hallowell B, Mahoney L, Daly M, Goulet J, et al.
Drug Alcohol Depend Rep
. 2024 Nov;
13:100287.
PMID: 39498372
Background: Certified peer recovery specialists (CPRS) and licensed clinical social workers (LCSWs) can facilitate substance use disorder (SUD) treatment engagement for emergency department (ED) patients at risk for overdose. Predictors...